Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.
Luckily for you, our mission at StockStory is to help you make money and avoid losses by sorting the winners from the losers. That said, here is one mid-cap stock with a long growth runway and two that may have trouble.
Two Mid-Cap Stocks to Sell:
Clorox (CLX)
Market Cap: $11.51 billion
Founded in 1913 with bleach as the sole product offering, Clorox (NYSE: CLX) today is a consumer products giant whose product portfolio spans everything from bleach to skincare to salad dressing to kitty litter.
Why Does CLX Give Us Pause?
- Products have few die-hard fans as sales have declined by 1.9% annually over the last three years
- Absence of organic revenue growth over the past two years suggests it may have to lean into acquisitions to drive its expansion
- Free cash flow margin shrank by 5.8 percentage points over the last year, suggesting the company is consuming more capital to stay competitive
Clorox’s stock price of $95.10 implies a valuation ratio of 15.6x forward P/E. Dive into our free research report to see why there are better opportunities than CLX.
Coupang (CPNG)
Market Cap: $28.24 billion
Founded in 2010 by Harvard Business School student Bom Kim, Coupang (NYSE: CPNG) is an e-commerce giant often referred to as the "Amazon of South Korea".
Why Is CPNG Not Exciting?
- Bad unit economics and steep infrastructure costs are reflected in its low gross margin of 29%
- Earnings per share fell by 40% annually over the last three years while its revenue grew, showing its incremental sales were much less profitable
- Poor free cash flow margin of 2% for the last two years limits its freedom to invest in growth initiatives, execute share buybacks, or pay dividends
Coupang is trading at $15.75 per share, or 2.5x forward price-to-gross profit. To fully understand why you should be careful with CPNG, check out our full research report (it’s free).
One Mid-Cap Stock to Watch:
Dynatrace (DT)
Market Cap: $11.41 billion
With its platform processing over 30 trillion pieces of IT performance data daily, Dynatrace (NYSE: DT) provides an AI-powered platform that helps organizations monitor, secure, and optimize their applications and IT infrastructure across cloud environments.
Why Are We Fans of DT?
- Winning new contracts that can potentially increase in value as its billings growth has averaged 24% over the last year
- Software is difficult to replicate at scale and results in a premier gross margin of 81.7%
- Robust free cash flow margin of 26.2% gives it many options for capital deployment
At $39.48 per share, Dynatrace trades at 5.1x forward price-to-sales. Is now the right time to buy? See for yourself in our in-depth research report, it’s free.
Stocks We Like Even More
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum - both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks - FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
